Mechanisms of Collateral Sensitivity to Fluorouracil of a Cis-diamminedichloroplatinum(II)-resistant Human Non-small Lung Cancer Cell Line

Overview

Journal Br J Cancer

Specialty Oncology

Date 1992 Jun 1

PMID 1319727

Authors

Y Sugimoto

Y Ohe

K Nishio

T Ohmori

T Morikage

Y Fujiwara

N Saijo

Affiliations

Soon will be listed here.

Abstract

A cisplatin(CDDP)-resistant subline of a human lung cancer cell line, PC-7/CDDP, was 4.7-fold more resistant to CDDP than the parent line in a colony-forming assay. The sensitivity of this cell line to anthracyclines, vinca-alkaloid, etoposide, mitomycin C, and bleomycin was similar to that of the parental line, PC-7. However, PC-7/CDDP exhibited 4-fold higher sensitivity to fluorouracil (FUra). Possible mechanisms associated with the collateral sensitivity to FUra were studied in PC-7/CDDP cells. The sensitivity of both cell lines to FUra did not correlate with the effect of FUra on RNA. On the other hand, FUra induced a greater reduction in dTTP pools and more single strand breaks in PC-7/CDDP than in PC-7 cells. These results suggest that the pathway for de novo deoxyribonucleotide synthesis may be a target for FUra in PC-7/CDDP cells. However, inhibition of thymidylate synthase after FUra treatment did not correlate with the DNA-directed activity of FUra. Based on the above findings, the decreased salvage synthesis of dTTP was considered a possible mechanism of the greater reduction of dTTP pools in PC-7/CDDP cells. However, the activity of dThd kinase was the same in both cell lines. In the presence of physiological concentrations of exogenous dThd in the serum, uptake of dThd was less in PC-7/CDDP cells than that in PC-7 cells. Our data suggest that FUra-induced cytotoxicity in PC-7/CDDP cells is associated with the inhibition of dTTP synthesis and that the decreased uptake of dThd is a possible mechanism of the collateral sensitivity to FUra in PC-7/CDDP cells.

References

Kohn K, Erickson L, Ewig R, Friedman C . Fractionation of DNA from mammalian cells by alkaline elution. Biochemistry. 1976; 15(21):4629-37. DOI: 10.1021/bi00666a013. View

Tanaka K, Yoshioka A, Tanaka S, Wataya Y . An improved method for the quantitative determination of deoxyribonucleoside triphosphates in cell extracts. Anal Biochem. 1984; 139(1):35-41. DOI: 10.1016/0003-2697(84)90386-5. View

Nottebrock H, Then R . Thymidine concentrations in serum and urine of different animal species and man. Biochem Pharmacol. 1977; 26(22):2175-9. DOI: 10.1016/0006-2952(77)90271-4. View

Fujiwara Y, Sugimoto Y, Kasahara K, Bungo M, Yamakido M, Tew K . Determinants of drug response in a cisplatin-resistant human lung cancer cell line. Jpn J Cancer Res. 1990; 81(5):527-35. PMC: 5918066. DOI: 10.1111/j.1349-7006.1990.tb02602.x. View

Bungo M, Fujiwara Y, Kasahara K, Nakagawa K, Ohe Y, Sasaki Y . Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair. Cancer Res. 1990; 50(9):2549-53. View

Ohe Y, Nakagawa K, Fujiwara Y, Sasaki Y, Minato K, Bungo M . In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines. Cancer Res. 1989; 49(15):4098-102. View

Hospers G, Mulder N, de Jong B, de Ley L, Uges D, Scheper R . Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro. Cancer Res. 1988; 48(23):6803-7. View

Jarvis S . Characterization of sodium-dependent nucleoside transport in rabbit intestinal brush-border membrane vesicles. Biochim Biophys Acta. 1989; 979(1):132-8. DOI: 10.1016/0005-2736(89)90533-6. View

Sobrero A, Bertino J . Endogenous thymidine and hypoxanthine are a source of error in evaluating methotrexate cytotoxicity by clonogenic assays using undialyzed fetal bovine serum. Int J Cell Cloning. 1986; 4(1):51-62. DOI: 10.1002/stem.5530040106. View

10.

Keyomarsi K, Moran R . Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells. Cancer Res. 1986; 46(10):5229-35. View

11.

Lonn U, Lonn S . Increased levels of DNA lesions induced by leucovorin-5-fluoropyrimidine in human colon adenocarcinoma. Cancer Res. 1988; 48(15):4153-7. View

12.

Park J, Collins J, Gazdar A, Allegra C, Steinberg S, Greene R . Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines. J Natl Cancer Inst. 1988; 80(19):1560-4. DOI: 10.1093/jnci/80.19.1560. View

13.

Tatsumi K, Fukushima M, Shirasaka T, Fujii S . Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts. Jpn J Cancer Res. 1987; 78(7):748-55. View

14.

Vijayalakshmi D, Belt J . Sodium-dependent nucleoside transport in mouse intestinal epithelial cells. Two transport systems with differing substrate specificities. J Biol Chem. 1988; 263(36):19419-23. View

15.

Andrews P, Velury S, Mann S, Howell S . cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res. 1988; 48(1):68-73. View

16.

Kraker A, Moore C . Accumulation of cis-diamminedichloroplatinum(II) and platinum analogues by platinum-resistant murine leukemia cells in vitro. Cancer Res. 1988; 48(1):9-13. View

17.

Jackman A, Taylor G, Calvert A, HARRAP K . Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717. Biochem Pharmacol. 1984; 33(20):3269-75. DOI: 10.1016/0006-2952(84)90089-3. View

18.

OGUR M, Rosen G . The nucleic acids of plant tissues; the extraction and estimation of desoxypentose nucleic acid and pentose nucleic acid. Arch Biochem. 1950; 25(2):262-76. View

19.

Howell S, ENSMINGER W, Krishan A, Frei 3rd E . Thymidine rescue of high-dose methotrexate in humans. Cancer Res. 1978; 38(2):325-30. View

20.

Fram R, Woda B, Wilson J, Robichaud N . Characterization of acquired resistance to cis-diamminedichloroplatinum (II) in BE human colon carcinoma cells. Cancer Res. 1990; 50(1):72-7. View